targeted therapy

February 14, 2018
Greg Guthrie, ASCO staff

Biosimilars and Cancer Care: An Expert Opinion

English
gregguthrie

In this podcast, Dr. Gary Lyman describes biosimilars for cancer treatment and why they are important. He also talks about why ASCO is releasing a statement on them today.

Read More >>
January 25, 2018
Greg Guthrie, ASCO staff

“An Amazing Year for Breast Cancer Research”

English
gregguthrie

In this podcast, Dr. Erica Mayer reviews research highlights from the San Antonio Breast Cancer Symposium. New insights into hormone therapy, targeted therapy, joint stiffness, and fertility preservation are covered.

Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 5, 2017
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2017: Advances in Immunotherapy for Multiple Myeloma and Mesothelioma, and Targeted Therapies for Non-Small Cell Lung Cancer and HER2-Positive Breast Cancer

English
gregguthrie

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer.

Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 4, 2017
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2017: Symptom Reporting Extends Lives, Shorter Chemotherapy for Some Colon Cancer Patients, and Targeted Therapy in BRCA-Related Breast Cancer

English
gregguthrie

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer.

Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 3, 2017
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing

English
gregguthrie

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.

Read More >>
July 19, 2016

TAPUR: Looking for Answers in Targeted Therapy

English

The Targeted Agent and Profiling Utilization Registry (TAPUR) study is ASCO’s first clinical trial. In this podcast, ASCO Chief Medical Officer Dr. Richard Schilsky discusses TAPUR and why it is important to patients and the medical community.

Read More >>

Pages

Subscribe to RSS - targeted therapy